Dechra Pharmaceuticals (LSE:DPH) Forward Dividend Yield % : 0.00% (As of Apr. 29, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals Forward Dividend Yield %?

As of today (2024-04-29), the Forward Annual Dividend Yield of Dechra Pharmaceuticals is 0.00%.

As of today (2024-04-29), the Trailing Annual Dividend Yield of Dechra Pharmaceuticals is 0.32%.

LSE:DPH's Forward Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.88
* Ranked among companies with meaningful Forward Dividend Yield % only.

Dechra Pharmaceuticals's Dividends per Share for the six months ended in Jun. 2023 was £0.13.

During the past 12 months, Dechra Pharmaceuticals's average Dividends Per Share Growth Rate was 9.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 11.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 14.50% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 14.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Dechra Pharmaceuticals was 52.50% per year. The lowest was 7.90% per year. And the median was 13.45% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Dechra Pharmaceuticals's Forward Dividend Yield %

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's Forward Dividend Yield % falls into.

Dechra Pharmaceuticals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Dechra Pharmaceuticals (LSE:DPH) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Dechra Pharmaceuticals Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

DPHAY:USA DPHl:UK 1PK:Germany

Address

24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA

Website

https://www.dechra.com

Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines